Gluten is a composite of storage proteins in wheat, barley, and rye, principally gliadin and glutenin. In most people these proteins are partially broken down by digestive enzymes and tolerated by the immune system. In celiac disease, however, an abnormal immune reaction to gluten peptides disrupts normal digestion and damages the small intestinal lining, producing malabsorption and systemic effects.
Mechanism: how digestion becomes immunogenic
Proteolytic enzymes leave behind relatively large gliadin peptides that resist complete digestion. Research by Alessio Fasano Massachusetts General Hospital identified zonulin as a modulator of intestinal permeability and showed that gluten exposure can upregulate zonulin, increasing epithelial leakiness and allowing gliadin peptides to cross into the lamina propria. There the enzyme tissue transglutaminase modifies gliadin by deamidation, increasing its affinity for antigen-presenting molecules HLA-DQ2 and HLA-DQ8. Individuals who carry these HLA types present deamidated gliadin to CD4 positive T cells, triggering an autoimmune inflammatory response that recruits cytotoxic lymphocytes and releases cytokines that injure enterocytes. Peter H.R. Green Columbia University and other gastroenterology experts describe how this cascade produces characteristic villous blunting and crypt hyperplasia, reducing the absorptive surface of the small intestine.
Serologic markers reflect this process. Autoantibodies against tissue transglutaminase and endomysium appear as part of the systemic immune response and are widely used in screening and monitoring. Daniel Leffler Beth Israel Deaconess Medical Center and colleagues have summarized evidence linking serology with intestinal damage and clinical outcomes in follow-up studies.
Clinical consequences and social context
The consequences of impaired gluten digestion in celiac disease extend beyond gastrointestinal symptoms. Loss of absorptive surface causes malabsorption of iron, calcium, folate, and fat-soluble vitamins, leading to anemia, reduced bone density, and neurologic symptoms in some patients. Dermatitis herpetiformis is a cutaneous manifestation tied to the same immune process. Untreated disease increases risk of complications such as refractory enteropathy and, rarely, enteropathy-associated T-cell lymphoma.
Diagnosis and effective management carry important cultural and territorial implications. A lifelong gluten-free diet typically allows mucosal healing and symptom resolution, but adherence can be challenging where wheat is a dietary staple or gluten-free foods are economically or logistically scarce. Changes in food availability, labeling regulations, and public awareness vary by country, affecting access and quality of life for people with celiac disease. Not all adverse reactions to wheat are celiac disease; nonceliac gluten sensitivity and wheat allergy remain distinct conditions requiring different approaches.
Understanding how celiac disease alters gluten digestion clarifies why precise diagnostic testing, genetic risk assessment, and dietary management are central to care. International and institutional research led by recognized experts has established the biological steps from resistant gliadin peptides to immune-mediated villous atrophy and continues to inform strategies for screening, long-term monitoring, and addressing social barriers to safe, nutritious gluten-free diets.